Literature DB >> 15963723

3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.

Bader A Salameh1, Hakon Leffler, Ulf J Nilsson.   

Abstract

Copper(I)-catalyzed addition of alkynes to methyl 3-azido-3-deoxy-1-thio-beta-D-galactopyranoside afforded stable and structurally simple 3-deoxy-3-(1H-1,2,3-triazol-1-yl)-1-thio-galactosides carrying a panel of substituents at the triazole C4 in high yields. The 3-(1H-[1,2,3]-triazol-1-yl)-1-thio-galactoside collection synthesized contained inhibitors of the tumor- and inflammation-related galectin-3 with Kd values as low as 107 microM, which is as potent as the natural disaccharide inhibitors lactose and N-acetyllactosamine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963723     DOI: 10.1016/j.bmcl.2005.05.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  α-Azido ketones. Part 7: synthesis of 1,4-disubstituted triazoles by the "click" reaction of various terminal acetylenes with phenacyl azides or α-azidobenzo(hetera)cyclanones.

Authors:  Krisztina Kónya; Szabolcs Fekete; Anita Abrahám; Tamás Patonay
Journal:  Mol Divers       Date:  2012-02-04       Impact factor: 2.943

2.  Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Authors:  Katharina H Ruebel; Alexey A Leontovich; Long Jin; Gail A Stilling; Heyu Zhang; Xiang Qian; Nobuki Nakamura; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

4.  Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.

Authors:  Ruud P M Dings; Nigam Kumar; Michelle C Miller; Melissa Loren; Huzaifa Rangwala; Thomas R Hoye; Kevin H Mayo
Journal:  J Pharmacol Exp Ther       Date:  2012-12-11       Impact factor: 4.030

5.  Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3.

Authors:  Carl Diehl; Olof Engström; Tamara Delaine; Maria Håkansson; Samuel Genheden; Kristofer Modig; Hakon Leffler; Ulf Ryde; Ulf J Nilsson; Mikael Akke
Journal:  J Am Chem Soc       Date:  2010-10-20       Impact factor: 15.419

6.  Significant rate accelerated synthesis of glycosyl azides and glycosyl 1,2,3-triazole conjugates.

Authors:  Rishi Kumar; Prakas R Maulik; Anup Kumar Misra
Journal:  Glycoconj J       Date:  2007-12-18       Impact factor: 2.916

7.  Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.

Authors:  Ruud P M Dings; Michelle C Miller; Irina Nesmelova; Lucile Astorgues-Xerri; Nigam Kumar; Maria Serova; Xuimei Chen; Eric Raymond; Thomas R Hoye; Kevin H Mayo
Journal:  J Med Chem       Date:  2012-05-30       Impact factor: 7.446

Review 8.  Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways.

Authors:  Kamil Seyrek; Max Richter; Inna N Lavrik
Journal:  Cell Death Differ       Date:  2019-03-22       Impact factor: 15.828

9.  The carbohydrate-binding site in galectin-3 is preorganized to recognize a sugarlike framework of oxygens: ultra-high-resolution structures and water dynamics.

Authors:  Kadhirvel Saraboji; Maria Håkansson; Samuel Genheden; Carl Diehl; Johan Qvist; Ulrich Weininger; Ulf J Nilsson; Hakon Leffler; Ulf Ryde; Mikael Akke; Derek T Logan
Journal:  Biochemistry       Date:  2011-12-07       Impact factor: 3.162

Review 10.  Advancements in the mechanistic understanding of the copper-catalyzed azide-alkyne cycloaddition.

Authors:  Regina Berg; Bernd F Straub
Journal:  Beilstein J Org Chem       Date:  2013-12-02       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.